A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics.
A double blind controlled trial of Bencard HDM (Migen) for the prophylaxis of asthma in a group of Zambian asthmatics failed to show any benefit. The trial results suggest that asthmatics can benefit from regular supervision and the position of prophylactic and therapeutic medication.